Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Public ClinicalTrials.gov record NCT05571059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Phase II Study to Determine the Safety and Efficacy of Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Ifetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Study identification
- NCT ID
- NCT05571059
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 30, 2024
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
- Last update posted
- Mar 4, 2026
2024 – 2027
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Biosolutions Clinical Research | La Mesa | California | 91942 | Recruiting |
| University of California San Francisco | San Francisco | California | 94143 | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville | Florida | 32224 | Recruiting |
| Miami VA Health System | Miami | Florida | 33125 | Recruiting |
| Northwestern Medicine | Chicago | Illinois | 60611 | Recruiting |
| Indiana University Health | Indianapolis | Indiana | 46202 | Recruiting |
| University of Kansas | Kansas City | Kansas | 66160 | Recruiting |
| University of Louisville | Louisville | Kentucky | 40202 | Recruiting |
| Beaumont Hospital, Royal Oak | Royal Oak | Michigan | 48073 | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | Recruiting |
| University of Rochester | Rochester | New York | 14642 | Recruiting |
| UNC Chapel Hill | Chapel Hill | North Carolina | 27514 | Recruiting |
| Bend Memorial Hospital | Bend | Oregon | 97701 | Recruiting |
| Temple University Hospital | Philadelphia | Pennsylvania | 19140 | Recruiting |
| Avera Research Institute | Sioux Falls | South Dakota | 57108 | Recruiting |
| Pulmonary & Sleep Specialists | Dickson | Tennessee | 37055 | Recruiting |
| Baylor University Medical Center | Dallas | Texas | 75246 | Recruiting |
| Premier Pulmonary Critical Care and Sleep Medicine | Denison | Texas | 75020 | Recruiting |
| UW Health University Hospital | Madison | Wisconsin | 53792 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05571059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 4, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05571059 live on ClinicalTrials.gov.